Published On: 10/29/2024
DIA RWE 2024 Research: Presentation by Nuvan Rathnayaka
At Target RWE, we are dedicated to enhancing the reliability and reproducibility of real-world evidence (RWE). Our latest research from the DIA Real-World Evidence (RWE) 2024 conference delves into advanced strategies designed to sharpen inter-team communication and minimize potential errors in RWE studies. Nuvan Rathnayaka, Target RWE Manager of Biostatistics, provides insights into this innovative approach and discusses how effective communication frameworks can drive more accurate real-world data analysis.
Watch the video below to gain a first-hand look at the presented research titled 'Seeing Eye to Eye: Enhancing Inter-Team Communication for Reproducible Real-World Evidence.'
About Target RWE
Target RWE generates real-world evidence (RWE) that informs strategic decisions across the drug development lifecycle. Our unique combination of clinical, analytical and technical expertise enables comprehensive insight generation from complete retrospective and prospective longitudinal patient journeys, with unparalleled scale and accuracy.
Visit our website to learn more: https://targetrwe.com/
Contact:
Kayla Slake
Senior Manager, Marketing
984.234.0268 ext 205
More News
-
11/18/2024
Target RWE Unveils Latest Developments in TARGET-Liver Disease and Cirrhosis Quality Collaborative Partnership with the American Association for the Study of Liver Diseases -
10/29/2024
DIA RWE 2024 Research: Presentation by Nuvan Rathnayaka -
10/29/2024
DIA RWE 2024 Research: Presentation by David Pritchard, PhD -
10/28/2024
New Research and Methodological Innovations Presented by Target RWE at DIA RWE 2024 -
10/24/2024
Transforming Healthcare Through Data: Ewa J. Kleczyk on Precision Medicine, Diversity, and AI Challenges